3 Indian Growth Stocks With Earnings Growth Over 27%

Global markets are reacting to renewed inflation concerns and shifting central bank policies, which keeps money flowing toward companies that can grow earnings even as borrowing costs stay higher. That puts fast growing Indian businesses with solid balance sheets in a useful spotlight. This article looks at three stocks from a high quality growth screener that filters for both earnings potential and financial health, and explains what sets each apart.

The three stocks highlighted here offer a compelling starting point if you want exposure to healthy, high growth potential businesses that still keep an eye on balance sheet strength. However, if you want the strongest names, these 44 best high growth potential stocks are at the top of the list.

Shaily Engineering Plastics (BSE:501423)

Overview: Shaily Engineering Plastics makes precision plastic components and high value drug delivery devices for global pharmaceutical, healthcare, consumer and industrial clients.

Operations: Shaily Engineering Plastics generates about ₹10.25b in revenue from customised plastic and other material components sold across its end markets.

Market Cap: ₹141.61b

Shaily Engineering Plastics fits the Healthy high growth potential theme through its pharma focused CDMO work and complex drug delivery hardware, where long contracts and regulatory barriers can support both earnings momentum and financial resilience.

"While the company is doubling GLP-1 pen capacity from 40 million to 80 million units, on the back of rising injectable therapies, any sharp move toward more effective oral formulations or alternative delivery technologies could erode device volumes over time and put structural pressure on long term revenue visibility."

The real swing factor is how one concentrated therapy cycle ultimately shapes future pricing power, capacity use and earnings quality.

That swing factor is exactly what the full narrative for Shaily Engineering Plastics unpacks, showing where earnings quality could decouple from headline device volumes.

Sky Gold and Diamonds (BSE:541967)

Overview: Sky Gold and Diamonds designs, manufactures and sells gold and diamond jewellery, with lab grown and American diamonds shaping its faster growth.

Operations: Sky Gold and Diamonds generates about ₹71.76b in revenue primarily from gold jewellery manufacturing, supported by its diamond centric offerings.

Market Cap: ₹155.29b

Sky Gold and Diamonds taps into the Healthy high growth potential theme through its push into lab grown and simulated diamond jewellery, where demand momentum and product mix can turn already strong earnings forecasts into something more powerful.

"Accelerating shift from unorganised to organised jewellery retail, supported by lightweight machine made designs and wider national distribution, is deepening wallet share with large chains and is expected to sustain high volume growth. This may help lift revenue and earnings driven by operating leverage."

The real test will come if one key funding assumption changes and suddenly puts pressure on both margins and growth pace.

If that funding pillar shifts, the full narrative for Sky Gold and Diamonds shows how Sky Gold and Diamonds' lab grown push could accelerate, stall, or quietly reshape the long term earnings mix.

Cemindia Projects (BSE:509496)

Overview: Cemindia Projects builds large marine and transport infrastructure across India, with coastal and port contracts anchoring its high growth potential.

Operations: Cemindia Projects generates about ₹102,051 million in Construction revenue, largely from projects within India where it records around ₹98,565 million.

Market Cap: ₹209.80b

Cemindia Projects gives this screener a very different flavour, with long duration marine and coastal contracts that can lock in visibility on both workloads and potential earnings momentum.

"Although Cemindia Projects has a sizeable order backlog of around ₹31,000 crores, execution on large contracts such as Vadhvan Port and several newly awarded projects is still in early stages with work yet to start or only at design and mobilization. This could keep revenue recognition below what this backlog might imply if these delays extend or recur."

The real turning point is whether one concentrated source of future work quietly reshapes margins, cash conversion and how dependable that backlog really feels.

If that concentration risk is on your mind, the full narrative for Cemindia Projects breaks down which contracts could quietly accelerate earnings quality and which might stall cash generation.

Seeking Fresh Alternatives With Real Potential

Fresh ideas move first. Screen for breakout momentum and under the radar stocks before the crowd catches them, while the data still matters.

• Review opportunities for resilient income from businesses structured to pay regular distributions and scan the 217 dividend fortresses.
• Explore companies involved in advanced computing technologies and review the 25 quantum computing stocks while these specialist plays may still be less widely followed.
• Follow companies supporting AI-related infrastructure and search the 94 AI infrastructure stocks to compare different infrastructure-focused opportunities.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com